MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trialFrancesco Giganti, Alex Kirkham, Brandon Whitcher et al.|European Radiology|2017Cited by 36
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M. Moore, Mark Emberton, Nicola L. Robertson et al.|The Journal of Urology|2016Cited by 28
MAPPED study design: A 6month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imagingNicola L. Robertson, Mark Emberton, Caroline M. Moore et al.|Contemporary Clinical Trials|2012Cited by 22
Prostate cancer detection using quantitative T<sub>2</sub> and T<sub>2</sub>‐weighted imaging: The effects of 5‐alpha‐reductase inhibitors in men on active surveillanceFrancesco Giganti, Alex Kirkham, Giulio Gambarota et al.|Journal of Magnetic Resonance Imaging|2017Cited by 22